About ADx NeuroSciences
ADx NeuroSciences is a company based in Ghent (Belgium) founded in 2011.. ADx NeuroSciences has raised $3.17 million across 4 funding rounds from investors including European Union. The company has 14 employees as of December 31, 2021. ADx NeuroSciences offers products and services including Biomarker Assays and Tailor-made Antibodies. ADx NeuroSciences operates in a competitive market with competitors including Cytox, Amprion, PeopleBio R&D, Durin Technologies and Adlyfe, among others.
- Headquarter Ghent, Belgium
- Employees 14 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Adx Neurosciences
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.17 M (USD)
in 4 rounds
-
Latest Funding Round
$588.08 K (USD), Grant
Nov 01, 2019
- Investors
-
Employee Count
14
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ADx NeuroSciences
ADx NeuroSciences offers a comprehensive portfolio of products and services, including Biomarker Assays and Tailor-made Antibodies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assays for quantifying biomarkers in neurodegenerative diseases
Custom antibodies for detecting specific disease markers
Funding Insights of ADx NeuroSciences
ADx NeuroSciences has successfully raised a total of $3.17M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $588.08 thousand completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $588,080
-
First Round
First Round
(12 Jul 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2019 | Amount | Grant - ADx NeuroSciences | Valuation |
investors |
|
| Mar, 2016 | Amount | Series B - ADx NeuroSciences | Valuation |
investors |
|
| Aug, 2013 | Amount | Series A - ADx NeuroSciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ADx NeuroSciences
ADx NeuroSciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ADx NeuroSciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ADx NeuroSciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Adx Neurosciences Comparisons
Competitors of ADx NeuroSciences
ADx NeuroSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytox, Amprion, PeopleBio R&D, Durin Technologies and Adlyfe, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Prognostic tests for assessing dementia risk are developed.
|
|
| domain | founded_year | HQ Location |
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
|
|
| domain | founded_year | HQ Location |
Immunoassays are developed for early detection of neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Developer of the diagnostic test for neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Develops biomarkers and diagnostic tests for amyloid-related diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Adx Neurosciences
Frequently Asked Questions about ADx NeuroSciences
When was ADx NeuroSciences founded?
ADx NeuroSciences was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is ADx NeuroSciences located?
ADx NeuroSciences is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.
Is ADx NeuroSciences a funded company?
ADx NeuroSciences is a funded company, having raised a total of $3.17M across 4 funding rounds to date. The company's 1st funding round was a Series A of $1.33M, raised on Jul 12, 2012.
How many employees does ADx NeuroSciences have?
As of Dec 31, 2021, the latest employee count at ADx NeuroSciences is 14.
What does ADx NeuroSciences do?
ADx NeuroSciences was founded in 2011 in Ghent, Belgium, within the biotechnology sector focused on neurodegenerative diseases. Biomarker assays are developed to detect indicators such as beta amyloid and tau in patient fluid samples, primarily cerebrospinal fluid, with emerging blood-based tests. Panels target Alzheimers disease, alongside Parkinsons disease, traumatic brain injury, and amyotrophic lateral sclerosis. Partnerships are maintained with Quanterix, Lilly, TauRx, and EuroImmun to support assay advancement.
Who are the top competitors of ADx NeuroSciences?
ADx NeuroSciences's top competitors include Amprion, PeopleBio R&D and Cytox.
What products or services does ADx NeuroSciences offer?
ADx NeuroSciences offers Biomarker Assays and Tailor-made Antibodies.
Who are ADx NeuroSciences's investors?
ADx NeuroSciences has 1 investor. Key investors include European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.